E57 How is AI reshaping the work of drug development?
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
E57 How is AI reshaping the work of drug development?
-
Lu par :
-
De :
À propos de cette écoute
Episode 57 of the Ask AI podcast features a conversation with Eric Sigel, a data scientist and biotech innovator with over 20 years of experience.
The discussion delves into how artificial intelligence is reshaping the future of scientific research, particularly in drug discovery, but not always at the expected pace or in anticipated ways.
Eric shares insights from his work at X-Chem, where he developed the scientific computing and data science infrastructure for their DNA-Encoded Library platform, and at ZebiAI, a spin-off company that applied machine learning to DEL technology and was acquired by Relay Therapeutics.
The episode explores the challenges of integrating AI into laboratory workflows, the bottlenecks that persist despite technological advancements, and the evolving skill sets required for scientists to keep pace with AI's rapid evolution.
For more details, please visit the episode post.
ABOUT ASK AI PODCASTAsk AI is an independent nonprofit that collaborates with volunteers, industry experts, and AI innovators to share free content and resources that help people spot the opportunities and navigate the challenges associated with the increased adoption of artificial intelligence at work. Visit: askai.org
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
